Related Experiment Video
Updated: Jun 20, 2025

Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
A preliminary prediction model of pediatric Mycoplasma pneumoniae pneumonia based on routine blood parameters by
Xuelian Peng1, Yulong Liu1, Bo Zhang1
1Department of Laboratory Medicine, The Affiliated Dazu's Hospital of Chongqing Medical University, Chongqing, 402360, China.
Background:
The prevalence and severity of pediatric Mycoplasma pneumoniae pneumonia (MPP) poses a significant threat to the health and lives of children. In this study, we aim to systematically evaluate the value of routine blood parameters in predicting MPP and develop a robust and generalizable ensemble artificial intelligence (AI) model to assist in identifying patients with MPP.
Methods:
We collected 27 features, including routine blood parameters and hs-CRP levels, from patients admitted to The Affiliated Dazu's Hospital of Chongqing Medical University with or without MPP between January, 2023 and January, 2024. A classification model was built using seven machine learning (ML) algorithms to develop an integrated prediction tool for diagnosing MPP. It was evaluated on both an internal validation set (982 individuals) and an external validation set (195 individuals). The primary outcome measured the accuracy of the model in predicting MPP.
Results:
The GBDT is state-of-the-art based on 27 features. Following inter-laboratory cohort testing, the GBDT demonstrated an AUC, accuracy, specificity, sensitivity, PPV, NPV, and F1-score of 0.980 (0.938-0.995), 0.928 (0.796-0.970), 0.929 (0.717-1.000), 0.926 (0.889-0.956), 0.922 (0.727-1.000), 0.937 (0.884-0.963), and 0.923 (0.800-0.966) in stratified 10-fold cross-validation. A GBDT-based AI Lab was developed to facilitate the healthcare providers in remote and impoverished areas.
Conclusions:
The GBDT-based AI Lab tool, with high sensitivity and specificity, could help discriminate between pediatric MPP infection and non-MPP infection based on routine blood parameters. Moreover, a user-friendly webpage tool for AI Lab could facilitate healthcare providers in remote and impoverished areas where advanced technologies are not accessible.
Insights
This study developed an AI model using routine blood tests to accurately predict pediatric Mycoplasma pneumoniae pneumonia (MPP). The tool aids healthcare providers in diagnosing MPP, especially in underserved regions.
Area of Science:
- Pediatric Infectious Diseases
- Artificial Intelligence in Medicine
- Biomarker Discovery
Background:
- Pediatric Mycoplasma pneumoniae pneumonia (MPP) presents a significant health challenge.
- Accurate and timely diagnosis of MPP is crucial for effective treatment.
- Existing diagnostic methods may have limitations in accessibility and speed.
Purpose of the Study:
- To evaluate the predictive value of routine blood parameters for pediatric MPP.
- To develop and validate a robust ensemble artificial intelligence (AI) model for MPP identification.
- To create a generalizable AI tool to assist healthcare providers in diagnosing MPP.
Main Methods:
- Collected 27 features, including routine blood parameters and hs-CRP, from pediatric patients.
- Developed an integrated prediction tool using seven machine learning (ML) algorithms.
- Validated the AI model on internal (982 individuals) and external (195 individuals) datasets.
Main Results:
- The Gradient Boosting Decision Tree (GBDT) model achieved high performance.
- Demonstrated an AUC of 0.980, accuracy of 0.928, sensitivity of 0.926, and specificity of 0.929.
- A GBDT-based AI Lab was developed for clinical use.
Conclusions:
- The GBDT-based AI Lab tool effectively discriminates pediatric MPP using routine blood parameters.
- The tool exhibits high sensitivity and specificity for MPP diagnosis.
- A user-friendly AI Lab webpage facilitates healthcare access in remote areas.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Pneumonia III: Complications and Assessment
Steps in Outbreak Investigation
Mechanistic Models: Compartment Models in Individual and Population Analysis